Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Projected Market Size Of The Artificial Intelligence In The Diagnostic Market By 2029?
The artificial intelligence in the diagnostic market size has experienced substantial growth in recent years. It is projected to increase from $4.29 billion in 2024 to $5.97 billion in 2025, achieving a compound annual growth rate (CAGR) of 39.1%. The expansion witnessed in the historic period can be attributed to factors such as a rising disease burden, data availability, cost reduction, regulatory support, and increasing awareness.
The artificial intelligence in the diagnostic market size is anticipated to undergo significant growth in the coming years. It is projected to achieve a value of $22.51 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 39.4%. This expansion during the forecast period can be linked to developments like personalized medicine trends, a rapid increase in healthcare data, global health challenges, boosted investments, and enhanced integration with healthcare systems. Prominent trends for the forecast period include growing collaboration and investment, technological advancements, data privacy and security considerations, the emergence of explainable AI (XAI), and the broadening application of computer vision.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13593&type=smp
Which Industry Drivers Are Expected To Accelerate The Artificial Intelligence In The Diagnostic Market From 2025 To 2029?
The expansion of AI in the diagnostics market is anticipated to be fueled by the increasing occurrence of chronic diseases. These conditions are defined as persistent health issues that typically last for an individual’s entire life. Integrating AI-driven diagnostic methods for chronic diseases allows for earlier detection, more accurate predictions, improved decision support systems, remote patient oversight, lower costs, and personalized treatments through analysis of genetic profiles and disease progression. A significant illustration comes from September 2023, when the World Health Organization, a specialized United Nations agency situated in Switzerland, reported 41 million fatalities annually worldwide. These fatalities constituted 74% of all non-communicable disease (NCD) or chronic disease-related deaths globally. Specifically, approximately 17.9 million deaths were linked to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. Consequently, the escalating occurrence of chronic illnesses is a key factor propelling the expansion of AI in the diagnostics market.
Which Key Segments Fueling The Artificial Intelligence In The Diagnostic Market?
The artificial intelligence in the diagnosticmarket covered in this report is segmented –
1) By Component: Hardware; Software; Services
2) By Technology: Machine Learning; NLP (Natural Language Processing); Context-Aware Computing; Computer Vision
3) By Diagnosis Type: Radiology; Pathology; Cardiology; Oncology; Neurology; Chest And Lung; Other Diagnosis Types
Subsegments:
1) By Hardware: Imaging Devices; Diagnostic Equipment; Wearable Devices
2) By Software: Diagnostic Imaging Software; Data Analytics Software; Machine Learning Algorithms; Clinical Decision Support Systems
3) By Services: Consulting Services; Integration Services; Maintenance And Support Services; Training Services
What Are The Latest Industry Trends Transforming The Artificial Intelligence In The Diagnostic Market?
Leading companies in the AI in diagnostics market are advancing new technologies, such as AI modules, to gain a competitive edge. An AI module functions as a self-contained software component that encapsulates specific AI functionalities or capabilities. For instance, in March 2023, Qritive, a Singapore-based provider of AI-powered solutions, introduced QAi Prostate for the diagnosis of prostate cancer. QAi Prostate is capable of efficiently recognizing the most common form of prostate cancer, potentially enhancing diagnostic accuracy and reducing false positive results. This tool assists pathologists in differentiating between cancerous and non-cancerous tissue areas, thereby aiding in informed treatment decisions. Furthermore, QAi Prostate can prioritize cases for accelerated diagnosis and reporting, improving both efficiency and patient care.
Which Key Market Players Are Investing In Expansion And Innovation Of Artificial Intelligence In The Diagnostic Market?
Major companies operating in the artificial intelligence in the diagnostic market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Paige.AI Inc., HeartFlow Inc., Aidoc Medical Ltd., AliveCor Inc., Butterfly Network Inc., Imagen Technologies, Digital Diagnostics Inc., Brainomix Ltd., NovaSignal Corp., Enlitic Inc., Nano-X Imaging LTD., EchoNous Inc., Zebra Medical Vision Ltd., Aidence B.V., Neural Analytics Inc., IDx Technologies Inc., icometrix N.V., Vuno Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Artificial Intelligence In The Diagnostic Market?
North America was the largest region in the artificial intelligence in diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in the diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Artificial Intelligence In The Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13593&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence In The Diagnostic Market 2025, By The Business Research Company
Artificial Intelligence Ai In Asset Management Global Market Report 2025
Artificial Intelligence In Accounting Global Market Report 2025
Artificial Intelligence Ai In Clinical Trials Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model